Intuitive Surgical, Inc. vs Quantumscape Corp — how do they compare? Intuitive Surgical, Inc. trades at $351.16 (market cap $125.08B), while Quantumscape Corp trades at $6.09 (market cap $3.62B). The key difference: Intuitive Surgical, Inc. is far larger — about 34.6× Quantumscape Corp's market cap. Which is the better fit depends on your goals.
| ISRG | QS | |
|---|---|---|
Market Cap | $125.08B | $3.62B |
Sector | Health | Consumer Cyclical |
52-Week High | $592.85 | $18.44 |
52-Week Low | $345.42 | $5.86 |
Enterprise Value | $116.45B | $2.79B |
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $350.06, down 1.34% on the day and near its 52-week low of $344.55. The stock is in a bearish technical trend despite strong fundamentals: Q2 2026 EPS beat estimates at $2.80 vs. $2.48 expected, revenue grew to $10.06B in 2025, and net income margin expanded to 28.45%. However, slowing U.S. procedure growth and a cautious 2026 outlook have pressured shares, with recent news highlighting a nearly 40% decline year-to-date.
The outlook remains mixed: robust profitability and a 69.6% analyst buy rating with a $504.56 consensus target suggest long-term value, but near-term risks include valuation concerns (P/E 40.5), competitive pressures, and macroeconomic headwinds. Investors face a divergence between solid execution and market sentiment driven by growth deceleration fears.
QuantumScape (QS) trades at $6.05, up 3.24% on the day, amid a bearish technical signal and negative profitability metrics. The company reported a net loss of $435.05 million in 2025, with negative ROE and ROA, while cash flow remains dependent on financing activities. Recent news highlights a joint research agreement with Honda, providing optimism around solid-state battery development, though earnings misses in recent quarters temper near-term expectations.
The outlook remains speculative with high execution risk as QS transitions from R&D to commercialization. Investor sentiment is cautious, reflected in analyst holds and sells, but partnerships like Honda offer long-term potential. Key risks include sustained losses, EV market demand volatility, and manufacturing scalability challenges against established competitors.
Trailing returns across standard periods
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →